| Q61061795 | A transmembrane C-terminal fragment of syndecan-1 is generated by the metalloproteinase ADAM17 and promotes lung epithelial tumor cell migration and lung metastasis formation |
| Q28818800 | A user's guide to cannabinoid therapies in oncology |
| Q51081657 | Activation of CB1 receptors by 2-arachidonoylglycerol attenuates vasoconstriction induced by U46619 and angiotensin II in human and rat pulmonary arteries. |
| Q54979576 | Activation of the Cannabinoid Type 2 Receptor by a Novel Indazole Derivative Normalizes the Survival Pattern of Lymphoblasts from Patients with Late-Onset Alzheimer's Disease. |
| Q60301978 | Anti-tumoral potential of MDA19 in human osteosarcoma via suppressing PI3K/Akt/mTOR signaling pathway |
| Q92862471 | Antitumor Cannabinoid Chemotypes: Structural Insights |
| Q38806270 | Antitumorigenic targets of cannabinoids - current status and implications |
| Q89044597 | Assessment of Cannabinoids Agonist and Antagonist in Invasion Potential of K562 Cancer Cells |
| Q36775401 | Attenuation of HIV-1 replication in macrophages by cannabinoid receptor 2 agonists |
| Q42052824 | Bladder cancer cell growth and motility implicate cannabinoid 2 receptor-mediated modifications of sphingolipids metabolism |
| Q39150873 | Bufalin attenuates cancer-induced pain and bone destruction in a model of bone cancer |
| Q36036102 | Cannabinoid Receptors Are Overexpressed in CLL but of Limited Potential for Therapeutic Exploitation |
| Q36592526 | Cannabinoid WIN55, 212-2 induces cell cycle arrest and inhibits the proliferation and migration of human BEL7402 hepatocellular carcinoma cells |
| Q89679208 | Cannabinoid receptor expression in non-small cell lung cancer. Effectiveness of tetrahydrocannabinol and cannabidiol inhibiting cell proliferation and epithelial-mesenchymal transition in vitro |
| Q40133231 | Cannabinoid receptor-2 agonist inhibits macrophage induced EMT in non-small cell lung cancer by downregulation of EGFR pathway. |
| Q38692926 | Cannabinoids as Modulators of Cell Death: Clinical Applications and Future Directions. |
| Q26866298 | Cannabinoids as therapeutic agents in cancer: current status and future implications |
| Q64226446 | Cannabinoids in cancer treatment: Therapeutic potential and legislation |
| Q40353502 | Clinical Significance of Cannabinoid Receptors CB1 and CB2 Expression in Human Malignant and Benign Thyroid Lesions |
| Q91627873 | Combined CB2 receptor agonist and photodynamic therapy synergistically inhibit tumor growth in triple negative breast cancer |
| Q36876630 | Combined antiproliferative effects of the aminoalkylindole WIN55,212-2 and radiation in breast cancer cells |
| Q28476823 | Crosstalk between chemokine receptor CXCR4 and cannabinoid receptor CB2 in modulating breast cancer growth and invasion |
| Q26766163 | Endocannabinoids as Guardians of Metastasis |
| Q40440272 | Evaluation of cannabinoid CB1 and CB2 receptors expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients' survival. |
| Q34419405 | FAAH inhibition enhances anandamide mediated anti-tumorigenic effects in non-small cell lung cancer by downregulating the EGF/EGFR pathway |
| Q39021630 | Functional selectivity at G-protein coupled receptors: Advancing cannabinoid receptors as drug targets |
| Q64080447 | Future Aspects for Cannabinoids in Breast Cancer Therapy |
| Q36676002 | Human lung-resident macrophages express CB1 and CB2 receptors whose activation inhibits the release of angiogenic and lymphangiogenic factors |
| Q52583978 | INSIGHT ON THE IMPACT OF ENDOCANNABINOID SYSTEM IN CANCER: A REVIEW. |
| Q38764188 | Inhibition of autophagy and enhancement of endoplasmic reticulum stress increase sensitivity of osteosarcoma Saos-2 cells to cannabinoid receptor agonist WIN55,212-2. |
| Q53533652 | Intrathecal Injection of JWH-015 Attenuates Bone Cancer Pain Via Time-Dependent Modification of Pro-inflammatory Cytokines Expression and Astrocytes Activity in Spinal Cord. |
| Q37223268 | Lipid mediators involved in the oxidative stress and antioxidant defence of human lung cancer cells. |
| Q64067150 | MDA19, a novel CB2 agonist, inhibits hepatocellular carcinoma partly through inactivation of AKT signaling pathway |
| Q36843205 | Modulation of breast cancer cell viability by a cannabinoid receptor 2 agonist, JWH-015, is calcium dependent |
| Q35287890 | Modulation of the tumor microenvironment and inhibition of EGF/EGFR pathway: novel anti-tumor mechanisms of Cannabidiol in breast cancer. |
| Q33728086 | Novel role of cannabinoid receptor 2 in inhibiting EGF/EGFR and IGF-I/IGF-IR pathways in breast cancer |
| Q89032389 | One-step, stereoselective synthesis of octahydrochromanes via the Prins reaction and their cannabinoid activities |
| Q28075903 | Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents |
| Q34471928 | Regulation of MMP-9 by a WIN-binding site in the monocyte-macrophage system independent from cannabinoid receptors |
| Q34781231 | Regulation of circulating endocannabinoids associated with cancer and metastases in mice and humans |
| Q64121652 | Striking lung cancer response to self-administration of cannabidiol: A case report and literature review |
| Q39388256 | Structure-dependent inhibitory effects of synthetic cannabinoids against 12-O-tetradecanoylphorbol-13-acetate-induced inflammation and skin tumour promotion in mice |
| Q34669534 | The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids |
| Q92924139 | The Endocannabinoid System: A Target for Cancer Treatment |
| Q38469671 | The evolving role of the endocannabinoid system in gynaecological cancer |
| Q38287745 | Therapeutic potential of cannabinoids in counteracting chemotherapy-induced adverse effects: an exploratory review |
| Q35639956 | Tumor-suppressive effects of psoriasin (S100A7) are mediated through the β-catenin/T cell factor 4 protein pathway in estrogen receptor-positive breast cancer cells |
| Q55248912 | ∆9-tetrahydrocannabinol inhibits epithelial-mesenchymal transition and metastasis by targeting matrix metalloproteinase-9 in endometrial cancer. |